Insider · CIK 0001847941

Farwell Wildon

Reports to the SEC for 1 company · WALTHAM, MA

sec.gov

Transactions

Companies

Filings

CIK

0001847941

Forms 4 and 5

Insider transactions

31 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-08-19	DYNDyne Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−2,060 sh	$45.01	−$92.7K	143,483
2024-08-19	DYNDyne Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−261 sh	$46.00	−$12K	143,222
2024-06-11	DYNDyne Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−1,628 sh	$31.27	−$50.9K	146,551
2024-06-11	DYNDyne Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−1,008 sh	$31.27	−$31.5K	145,543
2024-05-16	DYNDyne Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−1,956 sh	$28.20	−$55.2K	148,604
2024-05-16	DYNDyne Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−425 sh	$28.59	−$12.2K	148,179
2024-03-12	DYNDyne Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−1,030 sh	$25.58	−$26.3K	150,560
2024-03-11	DYNDyne Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−1,585 sh	$25.70	−$40.7K	151,590
2024-03-07	DYNDyne Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−8,364 sh	$25.80	−$216K	154,732
2024-03-07	DYNDyne Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−1,557 sh	$26.20	−$40.8K	153,175
2024-02-28	DYNDyne Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−407 sh	$25.00	−$10.2K	163,096
2024-02-12	DYNDyne Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−5,493 sh	$25.07	−$138K	163,503
2024-01-26	DYNDyne Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−100 sh	$25.00	−$2,500	168,996
2023-12-12	DYNDyne Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−978 sh	$10.55	−$10.3K	169,096
2023-12-11	DYNDyne Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−1,688 sh	$10.72	−$18.1K	170,074
2023-11-15	DYNDyne Therapeutics, Inc.A Award	Chief Medical Officer	AAward	+82.5K sh	—	—	171,762
2023-11-15	DYNDyne Therapeutics, Inc. · Stock Option (right to buy)A Award	Chief Medical Officer	AAward	+32.1K sh	—	—	32,131
2023-09-12	DYNDyne Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−1,707 sh	$10.41	−$17.8K	89,250
2023-06-13	DYNDyne Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−1,698 sh	$12.43	−$21.1K	90,957
2023-03-14	DYNDyne Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−7,441 sh	$13.33	−$99.2K	92,655
2022-12-12	DYNDyne Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−628 sh	$10.87	−$6,826.36	100,096
2022-12-09	DYNDyne Therapeutics, Inc.A Award	Chief Medical Officer	AAward	+36K sh	—	—	100,724
2022-12-09	DYNDyne Therapeutics, Inc. · Stock option (right to buy)A Award	Chief Medical Officer	AAward	+56K sh	—	—	56,000
2022-09-15	DYNDyne Therapeutics, Inc.D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−658 sh	$14.05	−$9,244.9	64,724
2022-06-14	DYNDyne Therapeutics, Inc.D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−668 sh	$4.95	−$3,306.6	65,382
2022-03-11	DYNDyne Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−640 sh	$8.73	−$5,587.2	66,050
2022-03-02	DYNDyne Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−5,617 sh	$8.56	−$48.1K	66,690
2021-12-10	DYNDyne Therapeutics, Inc.A Award	Chief Medical Officer	AAward	+22.3K sh	—	—	72,307
2021-12-10	DYNDyne Therapeutics, Inc. · Stock Option (right to buy)A Award	Chief Medical Officer	AAward	+67.9K sh	—	—	67,935
2021-03-02	DYNDyne Therapeutics, Inc.A Award	Chief Medical Officer	AAward	+50K sh	—	—	50,000
2021-03-02	DYNDyne Therapeutics, Inc. · Stock Option (right to buy)A Award	Chief Medical Officer	AAward	+250K sh	—	—	250,000

Recent filings

Accepted (ET)
Aug 204
Farwell Wildon0000950170-24-099125
SEC(opens sec.gov)
Jun 114
Farwell Wildon0000950170-24-072168
SEC(opens sec.gov)
May 174
Farwell Wildon0000950170-24-062079
SEC(opens sec.gov)
Mar 124
Farwell Wildon0000950170-24-030483
SEC(opens sec.gov)
Mar 114
Farwell Wildon0000950170-24-029609
SEC(opens sec.gov)
Feb 284
Farwell Wildon0000950170-24-022242
SEC(opens sec.gov)
Feb 144
Farwell Wildon0000950170-24-015259
SEC(opens sec.gov)
Jan 264
Farwell Wildon0000950170-24-008063
SEC(opens sec.gov)
Dec 124
Farwell Wildon0001209191-23-058328
SEC(opens sec.gov)
Nov 164
Farwell Wildon0001209191-23-055524
SEC(opens sec.gov)
Sep 134
Farwell Wildon0001209191-23-049362
SEC(opens sec.gov)
Jun 144
Farwell Wildon0001209191-23-037165
SEC(opens sec.gov)
Mar 154
Farwell Wildon0001209191-23-018979
SEC(opens sec.gov)

Companies

Dyne Therapeutics, Inc.Chief Medical OfficerDYN

Address

C/O DYNE THERAPEUTICS, INC. 830 WINTER STREET

WALTHAM, MA, 02451